Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pei-Jung Lin

Showing results (31-40 of 97) with videos related to

Pageof 10
Sort By:
The American Journal of Managed Care|July 18, 2008
Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 yearsThomas C Fenter, E Anne Davis, Manan B Shah, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Willingness to pay for diagnostic technologies: a review of the contingent valuation literaturePei-Jung Lin, Michael J Cangelosi, David W Lee, et al.
Journal of Managed Care & Specialty Pharmacy|June 23, 2022
When are breakthrough therapies cost-effective?Natalia Olchanski, Pei-Jung Lin, Wei-Shi Yeh, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2023
Estimating prevalence of early symptomatic Alzheimer's disease in the United StatesDrew Spargo, Richard Zur, Pei-Jung Lin, et al.
Journal of the American Geriatrics Society|June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After DiagnosisPei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Applied Health Economics and Health Policy|August 23, 2022
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?Ashley A Leech, Pei-Jung Lin, Brittany D'Cruz, et al.
Medical Care|September 30, 2009
The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementiasPei-Jung Lin, Andrea K Biddle, Rahul Ganguly, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Technology Assessment in Health Care|April 21, 2022
Is Value Portable? An Examination of Contextual and Practical Considerations that Affect the Transferability of Value Assessments between SettingsPatricia G Synnott, Pei-Jung Lin, Stacey S Hickson, et al.
Health Affairs (Project Hope)|April 9, 2014
Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's diseasePei-Jung Lin, Zhou Yang, Howard M Fillit, et al.
Pageof 10

Showing results (31-40 of 97) with videos related to

Sort By:
Pageof 10
The American Journal of Managed Care|July 18, 2008
Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 yearsThomas C Fenter, E Anne Davis, Manan B Shah, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Willingness to pay for diagnostic technologies: a review of the contingent valuation literaturePei-Jung Lin, Michael J Cangelosi, David W Lee, et al.
Journal of Managed Care & Specialty Pharmacy|June 23, 2022
When are breakthrough therapies cost-effective?Natalia Olchanski, Pei-Jung Lin, Wei-Shi Yeh, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 30, 2023
Estimating prevalence of early symptomatic Alzheimer's disease in the United StatesDrew Spargo, Richard Zur, Pei-Jung Lin, et al.
Journal of the American Geriatrics Society|June 14, 2016
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After DiagnosisPei-Jung Lin, Yue Zhong, Howard M Fillit, et al.
Applied Health Economics and Health Policy|August 23, 2022
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?Ashley A Leech, Pei-Jung Lin, Brittany D'Cruz, et al.
Medical Care|September 30, 2009
The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer disease and related dementiasPei-Jung Lin, Andrea K Biddle, Rahul Ganguly, et al.
The American Journal of Managed Care|April 17, 2015
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequencesPei-Jung Lin, David M Kent, Aaron Winn, et al.
International Journal of Technology Assessment in Health Care|April 21, 2022
Is Value Portable? An Examination of Contextual and Practical Considerations that Affect the Transferability of Value Assessments between SettingsPatricia G Synnott, Pei-Jung Lin, Stacey S Hickson, et al.
Health Affairs (Project Hope)|April 9, 2014
Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's diseasePei-Jung Lin, Zhou Yang, Howard M Fillit, et al.
Pageof 10